Access company data including market activity, funding rounds, last funding round price-per-share and valuation milestones. Use proprietary Forge Price data to track performance and monitor how company value changes over time.
Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.
Register| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4 |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids | $ Total Asks | # Bids | # Asks | Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
| Clearspeed | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $110MM | Series D-2 | 6/26/2025 | $30MM | $316.73MM | $1.42 | Align Private Capital, IronGate Capital Advisors, Bravo Victor Venture Capital, KBW Ventures, David Petraeus | |||||
| MBX Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $216.64MM | Series C | 8/5/2024 | $63.5MM | $316.71MM | $1.03 | Deep Track Capital, Driehaus Capital Management, T. Rowe Price Associates, Frazier Life Sciences, OrbiMed, Wellington Management | |||||
| Elucid Bioimaging | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $156.63MM | Series D | 10/10/2025 | $36.5MM | $316.49MM | $2.13 | Undisclosed Investors | |||||
| OrsoBio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $166.63MM | Series B | 9/6/2024 | $67MM | $316.32MM | $0.71 | Ascenta Capital, Woodline Partners, Samsara Biocapital, Longitude Capital, Enavate Sciences, NuevaBio, Eli Lilly and Company | |||||
| EndoQuest Robotics | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $207.22MM | Series D-2 | 7/14/2025 | $30.74MM | $316.22MM | $0.80 | Crescent Enterprises, Dr. Fred Moll, Puma Venture Capital, UTHealth Houston | |||||
| Motion | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $62.05MM | Series C-1 | 9/8/2025 | $32MM | $315.3MM | $18.12 | Scale Venture Partners, HOF Capital, 468 Capital, SignalFire, Y Combinator, Valor Equity Partners, Fellows Fund, Leonis Capital | |||||
| Indiegogo | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $71.61MM | Series B | 1/6/2016 | $54.85MM | $315.14MM | $7.39 | Institutional Venture Partners, Kleiner Perkins, Insight Venture Partners, MHS Capital, Metamorphic Ventures, FF Venture Capital, Runway Venture Partners | |||||
| Anomali | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $192.91MM | Series D | 1/17/2018 | $40MM | $315.13MM | $2.72 | Deutsche Telekom Capital Partners, General Catalyst, GV, IVP, Lumia Capital, Paladin Capital Group, Sozo Ventures, Telstra Ventures | |||||
| Pelage | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $150.75MM | Series B | 10/15/2025 | $120MM | $314.7MM | $7.23 | ARCH Venture Partners, GV, Main Street Advisors, Visionary Ventures, YK Bioventures | |||||
| Nuvolo | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $67.25MM | Series C | 3/2/2021 | $32MM | $314.3MM | $11.70 | Insight Partners | |||||
| Turquoise Health | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $96.49MM | Series C | 3/17/2026 | $36.46MM | $314.03MM | $11.72 | Oak HC/FT, Andreessen Horowitz, Adams Street Partners, Yosemite | |||||
| Bevy | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $61.68MM | Series C | 3/24/2021 | $40MM | $313.95MM | $13.25 | Accel, Upfront Ventures, Ryan Smith, LinkedIn | |||||
| Every | Foodtech Animal-Free Protein | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $286.7MM | Series D-2 | 11/4/2025 | $27.5MM | $313.94MM | $0.67 | McWin, Main Sequence Ventures, Bloom8, TO Ventures, Minerva Foods, Grosvenor Food & AgTech, New Agrarian, SOSV | |||||
| Forward Networks | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $118.59MM | Series D | 1/24/2023 | $50MM | $313.84MM | $5.67 | MSD Partners, Section 32, Omega Ventures, Goldman Sachs, Threshold Ventures, A. Capital, Andreessen Horowitz | |||||
| Klarity | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $90.53MM | Series B | 6/24/2024 | $70MM | $313.75MM | $23.22 | NFDG Ventures, Y Combinator, Tola Capital, Picus Capital, Invus Capital, Scale Venture Partners | |||||
| Adore Me | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $54.01MM | Series B | 3/14/2022 | $42.43MM | $313.73MM | $23.57 | Undisclosed Investors | |||||
| Cequence Security | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $102.19MM | Series C | 12/15/2021 | $66.63MM | $313.72MM | $2.01 | Menlo Ventures, ICON Ventures, Telstra Ventures, HarbourVest Partners, Shasta Ventures, Dell Technologies Capital, T-Mobile Ventures | |||||
| Comet | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $69.29MM | Series B | 11/18/2021 | $25MM | $313.67MM | $10.15 | OpenView, Scale Venture Partners, Trilogy Equity Partners, Two Sigma Ventures, GiTV, InvestInData | |||||
| Lycia Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $406.62MM | Series C | 5/13/2024 | $106.6MM | $313.67MM | $2.04 | Venrock Healthcare Capital Partners, Janus Henderson Investors, Marshall Wace, Franklin Templeton, Redmile Group, RTW Investments, Blue Owl Healthcare Opportunities, Invus, Eli Lilly and Company, Alexandria Venture Investments | |||||
| Gametime | Consumer & Lifestyle Entertainment | Low | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | $10.06 | +0.00% | -0.40% | $242.38MM | Series C | 5/26/2022 | $22.2MM | $313.63MM | $15.09 | Nimble Partners, John Burbank, Maven Ventures, Accel, GV, Jeff Mallett, Bolt Ventures, David Blitzer, Tenere Capital, Blitzscaling Ventures, Next Play Capital, Alumni Ventures, University Growth Fund, Palapa Ventures | |||||
| Septerna | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $225MM | Series B | 7/11/2023 | $150MM | $313.42MM | $1.23 | RA Capital Management, Third Rock Ventures, Samsara BioCapital, Invus, Catalio Capital Management, BVF Partners, Casdin Capital, Logos Capital, Deep Track Capital, Goldman Sachs Asset Management, Vertex Ventures HC, Mirae Asset Financial Group, Direhaus Capital Management, Woodline Partners LP, Soleus Capital | |||||
| Wildfire | Consumer & Lifestyle E-commerce Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $39.51MM | Series B-1 | 10/28/2024 | $15MM | $313.1MM | $12.60 | Intuit Ventures, Mucker Capital, Cohen Circle, Samsung Next, Evolution VC, Gaingels, TTV Capital, QED Investors, B Capital, DLA Piper, Moonshots Capital, Citi Ventures | |||||
| Pactum | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $108.15MM | Series C | 6/9/2025 | $54MM | $312.93MM | $8.18 | Insight Partners | |||||
| MarqVision | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $89.09MM | Series B-1 | 9/15/2025 | $42.81MM | $312.86MM | $25.52 | Peak XV Partners, HSG, Salesforce Ventures, Coral Capital | |||||
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.